CNS & Neurological Disorders - Drug Targets
Title:Dendrites, 3rd Edition
Volume: 16 Issue: 6
Author(s): M. Foster Olive*
Affiliation:
- Department of Psychology, Arizona State University, Tempe, Arizona 85287,United States
Export Options
About this article
Cite this article as:
Olive Foster M. *, Dendrites, 3rd Edition, CNS & Neurological Disorders - Drug Targets 2017; 16 (6) . https://dx.doi.org/10.2174/1871527316999170505104950
DOI https://dx.doi.org/10.2174/1871527316999170505104950 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
Current Pharmaceutical Design Cannabinoids and Sensory Neurones
Current Neuropharmacology Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer’s Disease Patients
Current Alzheimer Research Therapeutic Targeting of Chemokines with Monoclonal Antibodies
Current Immunology Reviews (Discontinued) Cucurbitacin E, An Experimental Lead Triterpenoid with Anticancer, Immunomodulatory and Novel Effects Against Degenerative Diseases. A Mini-Review
Current Topics in Medicinal Chemistry A Solvent-free Method for Synthesis of Dihydroangelicins using Microwaves
Current Green Chemistry Red Wine, Arterial Stiffness and Central Hemodynamics
Current Pharmaceutical Design Nanochemistry-Based Immunotherapy for HIV-1
Current Medicinal Chemistry Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
Current Alzheimer Research Non-Invasive Imaging of Human Embryonic Stem Cells
Current Pharmaceutical Biotechnology Science and Technological Understanding of Nano-ionic Resistive Memories (RRAM)
Nanoscience & Nanotechnology-Asia Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer’s Disease
Current Medicinal Chemistry HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Current HIV Research Synthesis and Biological Activity of Hydrazones and Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Current Neuropharmacology Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Introduction: P2 Receptors
Current Topics in Medicinal Chemistry Natural Products in Structure-Assisted Design of Molecular Cancer Therapeutics
Current Pharmaceutical Design Biomarkers for Radiographic Progression in Rheumatoid Arthritis
Current Pharmaceutical Design Peripheral Kynurenine Metabolism in Focal Dystonia
Medicinal Chemistry